Need Help?

Epigenomics and Single-cell Sequencing Define Cellular Heterogeneity in Langerhans Cell Histiocytosis

Epigenomic and transcriptomic analysis of Langerhans cell histiocytosis (LCH) biopsies. Single-cell RNA-seq (10x Genomics) of seven LCH biopsies. ATAC-seq data from four sorted cell populations (in duplicate) from one LCH biopsy.

Request Access

LCH data access policy

This agreement governs the terms on which access will be granted to the DNA (ATAC-seq) and RNA (single-cell transcriptomics) sequence data that have been generated in the LCH developmental hierarchy (LCH_hierarchy) study. These data are provided by St. Anna Children’s Cancer Research Institute (CCRI) and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. They are made available through the European Genome-phenome Archive (EGA). Definitions: * Data means all and any human genetic data (including genome, epigenome, transcriptome, and other large-scale data types and derived data) and phenotype data obtained from the EGA. * Data Subject means a person whose data is being shared with informed consent / ethical approval by the relevant ethics commission or institutional review board. * Data Provider means the St. Anna Children’s Cancer Research Institute (CCRI) and the CeMM Re-search Center for Molecular Medicine of the Austrian Academy of Sciences. * EGA means the European Genome-phenome Archive, a permanent archive of controlled access data generated for biomedical research and deposited to enable data sharing. The EGA is described on the website http://www.ebi.ac.ukl/ega. * User means a researcher whose User Institution has previously completed this Data Access Agree-ment and has received acknowledgement of its acceptance. * User Institution means the organisation at which the User is employed, affiliated or enrolled. Terms and Conditions: In signing this Agreement: 1. You agree to use the Data only for research in the areas of biology and medicine. 2. You agree to preserve, at all times, the confidentiality of information and Data pertaining to Data Subjects. In particular, You undertake not to use, or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on Data Subjects and their right to privacy. 3. You agree not to transfer or disclose the Data, in whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or programme management. Should You wish to share the Data with a collaborator outside the same Institution, the third party must make a separate application for access to the Data. 4. You agree to use the data for the approved purpose and project described in your application; use of the data for a new purpose or project will require a new application and a new approval. 5. You accept that the providers and the funders of the Data or any part of the Data: a) bear no legal responsibility for the accuracy or comprehensiveness of the Data; and b) accept no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data, or from the unavailability of, or break in access to, the Data for whatever reason. 6. You understand that duplication, except as reasonably required to carry out Your research with the Data, or sale of all or part of the Data on any media is not be permitted. 7. You accept that this agreement will terminate immediately upon any breach of this agreement by You. Upon termination You will be required to promptly destroy any Data held. 8. You accept that it may be necessary for the Data Provider or its appointed agents to alter the terms of this agreement from time to time in order to address new concerns. In this event, the EGA or its appointed agent will contact You to inform You of any changes and You agree that Your continued use of the Data shall be dependent on the parties entering into a new version of the Agreement. 9. You accept that the Data may be protected by and subject to laws and regulations, including but not limited to applicable laws on the protection of personal data, and that You are responsible for ensuring compliance with any such applicable law. You undertake to implement or have implemented adequate technical and organizational security measures to protect the Data.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003822 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002553651 bam 525.5 MB
EGAF00002553652 bam 604.6 MB
EGAF00002553653 bam 577.8 MB
EGAF00002553654 bam 737.6 MB
EGAF00002553655 bam 674.7 MB
EGAF00002553656 bam 718.7 MB
EGAF00002553657 fastq.gz 3.6 GB
EGAF00002553658 fastq.gz 4.7 GB
EGAF00002553659 fastq.gz 527.2 MB
EGAF00002553660 fastq.gz 697.9 MB
EGAF00002553661 fastq.gz 3.9 GB
EGAF00002553662 fastq.gz 6.2 GB
EGAF00002553663 fastq.gz 6.3 GB
EGAF00002553664 fastq.gz 10.3 GB
EGAF00002553665 fastq.gz 4.6 GB
EGAF00002553666 fastq.gz 7.4 GB
EGAF00002553667 fastq.gz 4.6 GB
EGAF00002553668 fastq.gz 8.0 GB
EGAF00002553669 fastq.gz 2.1 GB
EGAF00002553670 fastq.gz 7.2 GB
EGAF00002553671 fastq.gz 2.2 GB
EGAF00002553672 fastq.gz 7.6 GB
EGAF00002553673 fastq.gz 634.1 MB
EGAF00002553674 fastq.gz 995.2 MB
EGAF00002553675 fastq.gz 769.7 MB
EGAF00002553676 fastq.gz 774.8 MB
EGAF00002553677 fastq.gz 701.0 MB
EGAF00002553678 fastq.gz 755.2 MB
28 Files (88.3 GB)